Dr. J.B. van Rees

Dr. J.B. van Rees

Dr. J.B. (Hans) van Rees is cardioloog in opleiding. Hij is in 2011 gestart met de specialisatie tot cardioloog in het Leids Universitair Medisch Centrum.

In 2014 promoveerde hij op het onderwerp “Implantable Cardioverter Defibrillators: Translating evidence from randomized clinical into routine clinical practice”. Het onderzoek richtte zich onder andere op de selectie van patiënten die geschikt zijn voor een ICD, het voorkomen van onterechte ICD shocks en draadproblematiek. Hij wil zich specialiseren in de interventie cardiologie en zal zijn opleiding afronden in 2017.




Top-cited publications

206 times cited (±31/year) Source: Scopus

Journal of the American College of Cardiology, Volume 57, Issue 5, 01 February 2011, Pages 556-562 Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Abstract


125 times cited (±21/year) Source: Scopus

Journal of the American College of Cardiology, Volume 58, Issue 10, 01 August 2011, Pages 995-1000 Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. Abstract


42 times cited (±6/year) Source: Scopus

Pacing and clinical electrophysiology : PACE, Volume 33, Issue 8, 27 April 2010, Pages 1013-1019 Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Borleffs CJ, Thijssen J, de Bie MK, van Rees JB, van Welsenes GH, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Abstract


Most recent publications

01 Jan 2017

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Volume 19, Issue 1, 01 January 2017, Pages 72-80 Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment. van der Heijden AC, van Rees JB, Levy WC, van der Bom JG, Cannegieter SC, de Bie MK, van Erven L, Schalij MJ, Borleffs CJ. Abstract


04 Mrt 2015

Heart rhythm, Volume 12, Issue 6, 04 March 2015, Pages 1169-1176 The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications. van der Heijden AC, Borleffs CJ, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, Schalij MJ, van Erven L. Abstract


19 Aug 2014

European journal of heart failure, Volume 16, Issue 10, 19 August 2014, Pages 1104-1111 Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment. van der Heijden AC, Höke U, Thijssen J, Borleffs CJ, van Rees JB, van der Velde ET, Schalij MJ, van Erven L. Abstract